PATH
UiPath, Inc.
Next earnings Sep 2, 2026 · consensus $0.15 EPS, $406M rev
Last earnings +3.8% on 2026-05-28
$11.71
▲ +9.64%$11.71▼ -8.01%
over 1Y
L $9.38H $19.29
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today+9.6%
1W+17.9%
1M-3.9%
3M+4.2%
YTD-26.3%
1Y-8.0%
Buy
Conviction
Horizon
Long (>12mo)
12-mo target
$•••
Street · 28 analysts
Hold
UiPath turned GAAP-profitable with 83% gross margins and $371M cash flow at a reasonable 19.8x — but operating margin is thin and growth is slowing.
Net income $282M · FY2026
The read
Quality fundamentals and an attractive price line up (~69% below fair value) — the rarer case where both the business and the entry look good.
UiPath is the leader in robotic process automation (RPA), pivoting toward agentic AI automation. FY2026 marked a profitability inflection: net income swung to $282M from a -$73.7M loss, ending a multi-year string of losses (-$526M in FY2022 narrowing each year). Revenue grew 12.7% to $1.61B at an 83.2% software gross margin, and the business is solidly cash-generative with $371M of operating cash flow (+15.8%). The balance sheet is strong — $871M cash, just 0.53x liabilities/equity — and management returned capital via $329M of buybacks.
A careful read tempers the enthusiasm. Net margin (17.5%) far exceeds operating margin (3.5%), meaning the bulk of GAAP net income came from non-operating items (investment income and/or tax effects) rather than core operations — operating income was only $56.8M. So the headline profitability is real but not yet driven by a high-margin operating engine. R&D held roughly flat at $385M as the company invests in AI capabilities, and the 10-K warns it has non-cancellable multi-year cloud-capacity commitments and may not sustain consistent profitability.
AI-generated analysis, produced by our proprietary engine from SEC filing data.
Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jun 21, 2026, 5:00 PM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.
Financials · annual, by fiscal year
| Line item | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Revenue | $892M | $1.06B | $1.31B | $1.43B | $1.61B |
| Gross profit | $723M | $879M | $1.11B | $1.18B | $1.34B |
| Operating income | -$501M | -$348M | -$165M | -$163M | $56.8M |
| Net income | -$526M | -$328M | -$89.9M | -$73.7M | $282M |
| Diluted EPS | -$1.16 | -$0.60 | -$0.16 | -$0.13 | $0.52 |
| Net margin | -58.9% | -31.0% | -6.9% | -5.2% | 17.5% |
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Key statistics
Valuation
Enterprise value$5.20B
EV / EBITDA70.5
EV / Sales3.2
EV / FCF14.8
P / FCF17.2
PEG (trailing)0.05
Earnings yield4.7%
FCF yield5.8%
Quality & risk
ROIC (est.)2.2%
Free cash flow$352M
Total debt—
Net cash$871M
Altman Z-Score3.64 safe
Piotroski F-Score7/8
Capital returns
Buyback yield5.4%
Dividend yield (est.)—
Shareholder yield5.4%
Shares Δ YoY-3.9%
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
Disclosure timeline
SEC · 8-Ks + reportsSome governance/structural items recently, but no outright red flags.
Recent filings
all on EDGAR ↗4Period ending 2026-07-012026-07-02open ↗4Period ending 2026-07-012026-07-02open ↗4Period ending 2026-07-012026-07-02open ↗4Period ending 2026-07-012026-07-02open ↗4Period ending 2026-07-012026-07-02open ↗8-KPeriod ending 2026-06-252026-06-29open ↗4Period ending 2026-06-252026-06-29open ↗4Period ending 2026-06-252026-06-29open ↗4Period ending 2026-06-252026-06-29open ↗4Period ending 2026-06-252026-06-29open ↗4Period ending 2026-06-252026-06-29open ↗4Period ending 2026-06-252026-06-29open ↗
Frequently asked
- Is UiPath, Inc. (PATH) a buy?
- PATH currently carries a Buy rating with 3/5 conviction, derived from its latest SEC filings. UiPath turned GAAP-profitable with 83% gross margins and $371M cash flow at a reasonable 19.8x — but operating margin is thin and growth is slowing.
- What is PATH's fair value?
- A Modified-Graham model based on PATH's SEC fundamentals estimates a fair value of about $19.76. It is an estimate from reported earnings, not a price target.
- Is PATH overvalued or undervalued?
- Against a Modified-Graham fair-value estimate, PATH currently appears undervalued relative to its SEC-grounded earnings power.
- What is UiPath, Inc.'s quality score?
- PATH scores 71.58201434634557/100 (grade B) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.
Sources: SEC EDGAR (CIK 0001734722, latest 10-Q filed 2026-06-04) · EODHD · Proprietary analysis · as of 6/21/2026, 9:00:28 PM.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.